TT
Tasca Therapeutics Corp
SEC filingBiotechnology · Cambridge, MA
Amount raised$48.1Msold at filing
Total offering$70.2M$22.1M still open
Investors in the raise9count reported to the SEC
FiledDec 1, 2025first sale Nov 13, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Praveen TipirneniDirector
David FallaceDirector
Seth LieblichDirector
Michael AbermanDirector
Drew KingExecutive Officer
Milenko CicmilExecutive Officer, Director
Xu WuDirector
Executive officers, directors and promoters as listed on the Form D.